SCHEMBL2475865

SCHEMBL2475865

COc1cc2c(O)cc(/C=N/O)nc2c2ncccc12.COc1cc2c(SC)cc(/C=N/O)nc2c2ncccc12.CSc1cc(/C=N/O)nc2c1c(C)cc1cccnc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.36
CCR8 P51685 1/20 0.36
KDM4E B2RXH2 5/20 0.33
MAPK1 P28482 4/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
HSP90AA1 P07900 3/20 0.33
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
HTT P42858 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
MMP14 P50281 1/20 0.33
HPGD P15428 1/20 0.32
GAA P10253 3/20 0.32
RAB9A P51151 2/20 0.32
DYRK1A Q13627 1/20 0.31
NPC1 O15118 2/20 0.31
NSD2 O96028 1/20 0.31
CASP6 P55212 1/20 0.31
MITF O75030 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2475868 1.00 CCR1 (0.36) CCR1CCR8KDM4EMAPK1MEN1
SCHEMBL2472013 0.88
SCHEMBL2472275 0.87
SCHEMBL13372635 0.86 HSP90AA1 (0.41) KDM4EMAPK1MEN1KMT2AHSP90AA1
SCHEMBL3455965 0.86 HSP90AA1 (0.41) KDM4EMAPK1MEN1KMT2AHSP90AA1
SCHEMBL3455967 0.86 HSP90AA1 (0.41) KDM4EMAPK1MEN1KMT2AHSP90AA1
SCHEMBL3454980 0.83 HSP90AA1 (0.44) KDM4EMAPK1MEN1KMT2AHSP90AA1
SCHEMBL13372702 0.83 CCR1 (0.43) CCR1CCR8KDM4EMAPK1MEN1
SCHEMBL2476556 0.83 CCR1 (0.43) CCR1CCR8KDM4EMAPK1MEN1
SCHEMBL2476558 0.83 CCR1 (0.43) CCR1CCR8KDM4EMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373650-A1 TRIPLE SUBSTITUTED PHENANTHROLINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE OR HAEMATOLOGICAL DISEASES OR CONDITIONS, OR CANCER Noscira, S.A. (ES) 2011-10-12 EP claimed
WO-2010066832-A1 TRIPLE SUBSTITUTED PHENANTHROLINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE OR HAEMATOLOGICAL DISEASES OR CONDITIONS, OR CANCER NOSCIRA, S.A. (ES) 2010-06-17 WO claimed